Lumexa Imaging Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Lumexa Imaging Holdings, Inc. (LMRI) on January 12, 2026. The report discloses the resignation of a senior executive officer and the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the executive transition package:
- Transition Payment: $450,000
- 2025 Performance Bonus: $250,000
- Healthcare Coverage: Up to 12 months of subsidized coverage
Material Changes
The primary material change is the departure of Ms. Julie Szeker, Chief Legal Officer and Corporate Secretary. Her resignation is effective March 13, 2026. The filing explicitly states that the resignation was not the result of any disagreement with the Company regarding operations, policies, or practices. The Company has initiated a search for a successor.
Outlook, Risks, and Unusual Items
Management commentary is limited to the executive departure. The transition payments and bonus are contingent upon Ms. Szeker's execution and non-revocation of a release of claims and compliance with the Transition Agreement. No specific risks, contingencies, or unusual items beyond this personnel change are disclosed in this filing.
Investor Verification Checklist
- Verify the terms of the Transition Letter Agreement filed as Exhibit 10.1.
- Monitor future filings for the appointment of a new Chief Legal Officer and Corporate Secretary.
- Confirm the timing of the $250,000 bonus payment relative to the Company's standard annual bonus schedule.
- Review the Company's most recent 10-K or 10-Q for baseline financial performance, as this 8-K contains no operational financial data.